| CAS No. | 1609-72-9 |
| Molecular Formula | C7H13O3P |
| Molecular Weight | 176.15 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Under current pharmacopoeial and regulatory frameworks, quality-control requirements for this class of reference material explicitly involve the control of targets including Fosfomycin Impurity 17.
CATO supplies Fosfomycin Impurity 17 (CAS 1609-72-9), a pharmacopoeial impurity reference standard (molecular formula C7H13O3P, MW 176.15 g/mol) used for the identification and quantification of trace impurities in APIs.
The molecular framework of Fosfomycin Impurity 17 (C7H13O3P) is characterized by a phosphonate group, a carboxylic acid group, a hydroxyl group, an ether linkage. In reversed-phase chromatography, its retention is governed primarily by the polarity and ionization state of its functional groups, which provides a practical basis for HPLC-UV/DAD or LC-MS method development.
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
The assigned purity is verified by mass-balance and quantitative NMR (qNMR) approaches, with the expanded uncertainty reported at a 95% confidence level (k=2). Batch homogeneity and stability are independently assessed for every lot.
| Molecular Formula | C7H13O3P |
| Molecular Weight | 176.15 g/mol |
| Purity | >95% |
| Storage | Store at 2-8°C, keep sealed and dry |
| Solubility (reference) | Soluble in methanol, ethanol, DMSO, water |
| Stability | Hygroscopic; reseal immediately after opening |
| Degree of Unsaturation (DBE) | 1.5 |
| CAS Registry Year (est.) | 1957 |